Phase II, Multicenter Vaccination of Patients With Chronic Myelogenous Leukemia With a Multivalent Tumor Specific Breakpoint Peptide Vaccine.
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2013
At a glance
- Drugs Chronic myeloid leukaemia vaccine (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Nov 2005 New trial record.